A double-blind study was performed in a group of patients with lepromatous leprosy to evaluate the response of IgM and IgA serum levels and of serum titles of rheumatoid factor and isohemaglutinins anti-A and anti-B to administration of thalidomide 100 mg each day, for 18 days. No significant effect was detected at the end of the study.